Financials
Financial year 2025
INTERNATIONALE APOTHEEK from Antwerpen, company number BE0404790106, closed financial year 2025 with a result of € -24,204 after tax. For that financial year INTERNATIONALE APOTHEEK recorded a gross margin of € 117,507 and equity of € 190,080. Compared with financial year 2024, the result moved from € 22,576 to € -24,204. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
€ 190,080
▼ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -24,204
▼ still € 22,576 profit in 2024
Profit after tax over the fiscal year.
€ 111,431
▲ 157% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 10,357.
People and assets in 2025
2.2
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 122,778
▲ 29% vs 2024
€ 55,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,957
▼ 24% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 276,090
▼ 20% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 16,146
▲ 151% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 175,775 | € 175,713 | € 141,064 | € 117,507 | ▼ 17% |
| Profit after taxes | € 62,781 | € 39,269 | € 22,576 | € -24,204 | ▼ € 46,780 |
| Equity | € 214,284 | € 214,284 | € 214,284 | € 190,080 | ▼ 11% |
| Total debts | € 541,180 | € 409,954 | € 373,450 | € 292,923 | ▼ 22% |
| Cash | € 158,283 | € 109,858 | € 43,345 | € 111,431 | ▲ 157% |
| Land & buildings | € 140,504 | € 133,555 | € 127,266 | € 120,977 | ▼ 5% |
| Retained profit | € 34,561 | € 34,561 | € 34,561 | € 10,357 | ▼ 70% |
| Dividend | € 62,781 | € 39,269 | € 22,576 | € 0 | ▼ 100% |
| Bank debt | € 47,374 | € 22,678 | € 0 | € 0 | |
| Balance sheet total | € 755,464 | € 624,238 | € 587,734 | € 483,003 | ▼ 18% |
| Employees (FTE) | 1.4 | 2.3 | 2.1 | 2.2 | ▲ 0.1 |
Key figures of INTERNATIONALE APOTHEEK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to INTERNATIONALE APOTHEEK?
What happened at INTERNATIONALE APOTHEEK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 24,204 (▼ € 46,780 vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Antwerpen. KBO
In short
From € 62,781 profit in 2022 to € 24,204 loss in 2025.
Paid € 13,478 in corporate taxes since 2022.
Best year ever: 2022, with € 62,781 profit.
On average € 53,400 of value added per employee in 2025.
A new publication or filing at INTERNATIONALE APOTHEEK? We notify you, reason included.
Follow INTERNATIONALE APOTHEEKDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ANTWERP PHARMACIES comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
INTERNATIONALE APOTHEEKBehind INTERNATIONALE APOTHEEK are Antwerp Pharmacies BV and Jeff Roskams Consulting BV. The shares are held by ANTWERP PHARMACIES (100%).
Directors
According to the 2025 annual accounts
Director · represented by Joris Mees
Also active at: APOTHEEK VERLINDEN, APOTHEEK R. KROLS b.v.b.a., APOTHEEK VAN DEUN, APOTHEEK SUYKERBUYK, APOTHEEK DIRK VAN HERCK, Farmajes, APOTHEEK PALEIS, EUROPA APOTHEEK
Director · represented by Jeff Roskams
Also active at: APOTHEEK VERLINDEN, ANTWERP PHARMACIES
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Appelmansstraat 11
2018 Antwerpen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0404.790.106
- VAT number
- BE 0404.790.106
- Registered office
- Appelmansstraat 11, 2018 Antwerpen
- Names & denominations
- INTERNATIONALE APOTHEEK
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 17 March 1952
- Peppol
- Active · Active since 23 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers